| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |